News from the healthcare data industry
February 26, 2022—Phoenix, Arizona—Use of benralizumab in patients aged 12 and over with severe eosinophilic asthma results in significant reduction in asthma exacerbations, oral corticosteroid use, and healthcare resources utilization,...
DURHAM, N.C., March 8, 2022 /PRNewswire/ — A new TARGET-IBD study analysis shows one-third of patients with inflammatory bowel disease (IBD) did not have a record of objective disease activity assessment or therapeutic...
March 08, 2022 08:00 AM Eastern Standard Time CAMBRIDGE, Mass. & NEW YORK–(BUSINESS WIRE)–Cognito Therapeutics, a pioneer in developing disease-modifying therapeutic interventions for neurodegenerative diseases, and Aetion, a global real-world evidence...
ABSTRACT BACKGROUND: Disparities in access, utilization and outcomes exist throughout the healthcare system for minority groups, including racial and ethnic minorities; these disparities have wide-reaching implications for individuals as well...
Findings highlight the unmet medical need among cancer patients with BRAF Class II and Class III alterations who may not have access to approved targeted therapies SAN FRANCISCO and SAN...
SAN FRANCISCO, March 3, 2022 /PRNewswire/ — NephroSant™ a biotechnology company dedicated to accelerating the diagnosis of early kidney damage in native and transplanted kidneys, with a mission to significantly improve global kidney...
Abstract The landscape for evidence generation in hematologic malignancies is rapidly evolving. While randomized controlled trials (RCTs) remain the gold standard in support of drug efficacy, approval and use, the...
“Hotspot mapping” accelerates early-phase drug design CCDC, Exscientia, and Oxford University collaborate on an automated, quantitative method for informing the design of compound selectivity across protein families Cambridge Crystallographic Data...
Posted on March 2, 2022 BC Platforms (BCP), a global leader in healthcare data management and analytics, today announced expansion of its R&D operations in Singapore, which spearheads precision medicine...
Abstract Objective: To investigate the frequency of PSA testing in men receiving TT and with a history of PCa. Methods: We queried the TriNetX network database, a global health research network consisting...